- Report
- February 2024
- 70 Pages
Latin America
From €4195EUR$4,750USD£3,669GBP
- Report
- August 2023
- 90 Pages
Global
From €4195EUR$4,750USD£3,669GBP
- Report
- August 2023
- 70 Pages
Africa, Middle East
From €4195EUR$4,750USD£3,669GBP
- Report
- August 2023
- 70 Pages
South Korea
From €4195EUR$4,750USD£3,669GBP
- Report
- April 2023
- 110 Pages
Global
From €4195EUR$4,750USD£3,669GBP
- Report
- October 2022
- 70 Pages
Africa
From €4195EUR$4,750USD£3,669GBP
- Report
- August 2023
- 150 Pages
North America
From €4195EUR$4,750USD£3,669GBP
- Report
- June 2024
- 183 Pages
Global
From €3974EUR$4,500USD£3,476GBP
- Report
- May 2024
- 139 Pages
Global
From €4878EUR$5,524USD£4,267GBP
€5739EUR$6,499USD£5,020GBP
- Report
- May 2024
- 128 Pages
Global
From €4878EUR$5,524USD£4,267GBP
€5739EUR$6,499USD£5,020GBP
- Report
- May 2024
- 140 Pages
Global
From €4878EUR$5,524USD£4,267GBP
€5739EUR$6,499USD£5,020GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4195EUR$4,750USD£3,669GBP
- Report
- October 2022
- 286 Pages
Global
From €2208EUR$2,500USD£1,931GBP
- Report
- July 2025
- 200 Pages
India
From €2463EUR$2,789USD£2,154GBP
- Report
- August 2024
- 150 Pages
Global
From €2463EUR$2,789USD£2,154GBP
- Report
- June 2025
- 81 Pages
From €3047EUR$3,450USD£2,665GBP
- Report
- March 2023
- 26 Pages
Global
€10818EUR$12,250USD£9,462GBP
- Report
- October 2024
- 86 Pages
Global
From €3500EUR$4,246USD£3,169GBP
- Report
- September 2024
- 98 Pages
Global
From €3500EUR$4,246USD£3,169GBP
- Report
- February 2024
- 108 Pages
Global
From €3500EUR$4,246USD£3,169GBP

Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects.
The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more